Decentralized Digital Clinical Research Accelerates Drug Discovery to Care with Dr. Francesca Rinaldo Sharecare TRANSCRIPT
Download PDFOct 12, 2021
Francesca Rinaldo MD Ph.D. is the Director of Clinical Quality and Innovation at Sharecare, a health and wellness engagement platform. Their SmartOmix solution allows researchers to build, launch, manage and analyze data from clinical studies using a participant-centric mobile application that leverages all the technological components of a smartphone including text-based reporting, photo, video, and audio samples.
Francesca explains, "So, in my opinion, the future of clinical research is really three things: it's decentralized, it's digital-first, and it's widely inclusive. So, I think technology will impact researchers, patients, and doctors and a number of different ways. It will impact researchers because it will give them access to data that will provide a much more comprehensive view of health and wellness, as well as how disease trajectories change for study participants."
"It will also impact patients because it will accelerate the cycle from research to care, fast-track insights, and novel approaches to therapy or new drugs into the system for participants. And as we said before, it will also decrease many barriers for patients to participate in clinical research and increase the validity of the evidence generated because the research will be conducted in much more diverse populations of patients."
@SharecareInc #Sharecare #AI #ClinicalResearch #FutureisDigitalHealth #FutureofHealthcare #FutureofClinicalResearch #AIinHealth #TechinHealthcare #VirtualCare #Telemedicine #PatientCentric #HybridHealthcare #AllTogetherBetter
